1. Home
  2. XBP vs TOI Comparison

XBP vs TOI Comparison

Compare XBP & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XBP

XBP Europe Holdings Inc.

HOLD

Current Price

$4.15

Market Cap

47.0M

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.12

Market Cap

327.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBP
TOI
Founded
2020
2007
Country
United States
United States
Employees
10998
N/A
Industry
Business Services
Medical/Nursing Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.0M
327.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XBP
TOI
Price
$4.15
$3.12
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.67
AVG Volume (30 Days)
9.7K
2.2M
Earning Date
03-19-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.15
Revenue Next Year
N/A
$25.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$1.14
52 Week High
$8.55
$4.88

Technical Indicators

Market Signals
Indicator
XBP
TOI
Relative Strength Index (RSI) 33.26 53.01
Support Level $3.31 $2.17
Resistance Level $8.46 $3.83
Average True Range (ATR) 0.57 0.30
MACD -0.00 -0.02
Stochastic Oscillator 13.17 36.79

Price Performance

Historical Comparison
XBP
TOI

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. By combining innovation with execution excellence, XBP Global helps businesses reimagine business process automation and enable digital transformation.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Share on Social Networks: